METHODS FOR INHIBITING CARCINOGENESIS AND/OR METASTASIS IN AN INDIVIDUAL WITH ENDOGENOUS C-MET LIGANDS AND INHIBITORS

摘要

Methods for inhibiting carcinogenesis and/or metastasis in an individual comprise administering to the individual an effective amount of endogenous c-met ligand or fragment thereof such as endogenous anti c-met immunoglobulin, native and/or recombinant; endogenous biological active Hepatocyte Growth Factor (HGF), native and/or recombinant, and/or a combination thereof.